Apigenin's Effects on Multiple Myeloma Cells
Author Information
Author(s): Zhao Ming, Ma Jian, Zhu Hai-Yan, Zhang Xu-Hui, Du Zhi-Yan, Xu Yuan-Ji, Yu Xiao-Dan
Primary Institution: Department of Stress Medicine, Institute of Basic Medical Sciences, Cognitive and Mental Health Research Center, Beijing, China
Hypothesis
Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells by targeting CK2, Cdc37, and Hsp90.
Conclusion
Apigenin effectively inhibits multiple myeloma cell growth and induces apoptosis by disrupting key signaling pathways.
Supporting Evidence
- Apigenin showed cytotoxicity against multiple myeloma cell lines and primary cells.
- It inhibited CK2 kinase activity and reduced phosphorylation of Cdc37.
- Apigenin downregulated antiapoptotic proteins, leading to increased apoptosis.
- Combination treatments with other inhibitors enhanced the effects of apigenin.
Takeaway
Apigenin is a natural compound that can help kill cancer cells in multiple myeloma by stopping them from growing and making them die.
Methodology
The study used cell viability assays, western blot analysis, and flow cytometry to assess the effects of apigenin on multiple myeloma cells.
Limitations
The study primarily focused on in vitro experiments, and the effects in vivo may differ.
Participant Demographics
Patients with multiple myeloma, with a sample size of 12.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website